Beta-blocker use in elderly patients with coronary heart disease

Kelly, James; Kelleher, Kevin
January 2000
Age & Ageing;Jan2000, Vol. 29 Issue 1, p17
Academic Journal
Presents information on a study which examined the evidence that beta-blockers are effective treatment in elderly patients with coronary heart disease. Evidence of beta-blockers' under-use in elderly patients with myocardial infarction; Tolerability of the blockers in elderly patients; Conclusions.


Related Articles

  • Acute Coronary Syndromes – Beyond Myocyte Necrosis. Rabbani, LeRoy E. // New England Journal of Medicine;10/4/2001, Vol. 345 Issue 14, p1057 

    The article looks at the treatments of acute coronary syndromes. According to the author, advances in revascularization techniques have been paralleled by developments in drug treatment. He asserts that a typical approach to the acute coronary syndromes includes multiple treatment options such...

  • Carvedilol: Just Another Beta-Blocker or a Powerful Cardioprotector? Carreira, R. S.; Monteiro, P.; Gon�alves, L. M.; Provid�ncia, L. A. // Cardiovascular & Haematological Disorders - Drug Targets;Dec2006, Vol. 6 Issue 4, p257 

    Beta-blockers have been used to treat ischemic heart disease, due to negative chronotropic and inotropic properties, thus inducing a decrease in myocardial consumption of oxygen and nutrients, allowing a better balance between nutritional needs and the supply provided by the coronary blood flow....

  • Study: Long-Term Use of Clopidogrel for DES Patients.  // Clinical Oncology Alert;Jan2007, Vol. 23 Issue 1, Special section p1 

    The article covers issues related to pharmacology. It cites that patients with coronary artery disease who have been given intra-coronary, drug-eluding stents (DES) may benefit from long-term use of clopidogrel. A study in the "Annals of Internal Medicine" states that patients tend to...

  • What Is the Role of Beta Blocker Therapy in the Treatment of Hypertension? Basile, Jan; Cockcroft, John; Gradman, Alan // Medical Roundtable: Cardiovascular Edition;Winter2010, Vol. 1 Issue 1, p25 

    The discussion focused primarily on: (1) classification of different types of beta blockers, (2) beta blockers as initial and secondary therapy, (3) use of beta blockers in patients with compelling indications, such as coronary heart disease and heart failure, (4) the AB/CD rule, (5) therapy for...

  • Myocardial infarction with angiographically normal coronary arteries. Chandrasekaran, B.; Kurbaan, A. S. // Journal of the Royal Society of Medicine;Aug2002, Vol. 95 Issue 8, p398 

    The article focuses on the myocardial infarction with normal coronary arteries (MINCA). MINCA symptoms and electrocardiographic (ECG) findings were similar to myocardial infarction (MI) with angiographic colonary disease except in its infarct size that tend to be smaller. Information related to...

  • Betim.  // Royal Society of Medicine: Medicines;2002, p113 

    The article presents information on Betim, a proprietary, prescription-only preparation drug of the beta-blocker timolol maleate. This drug can used as an antihypertensive for high blood pressure, as an anti-angina treatment to relieve symptoms and improve exercise tolerance and to treat...

  • A critical evidence-based summary of the use of beta-blockers in stable coronary artery disease. Cartwright, Andrea Lynn; Wilby, Kyle John // Avicenna (2220-2749);2014, p66 

    Current clinical recommendations for patients with stable coronary artery disease (CAD) and those post-acute coronary syndromes (ACS) suggest initiation of patients on dual antiplatelet therapy, an angiotensin-converting enzyme (ACE) inhibitor, a beta-blocker and an HMG-CoA reductase inhibitor...

  • Drug options for angina little changed. Mann, Stewart // New Zealand Doctor;3/11/2009, p22 

    The article focuses on the drug options for angina which include nitrates, beta-blockers and calcium channel blockers. Nitrates are said to have been known to be valuable for the relief of angina symptoms but patients given nitrates are cautioned about possible headache and hypotension....

  • Health and Economic Benefits of Increased Beta-Blocker Use Following Myocardial Infarction. Phillips, Kathryn A.; Shilipak, Michael G.; Coxson, Pam; Heidenreich, Paul A.; Hunink, M. G. Myriam; Goldman, Paula A.; Williams, Lawrence W.; Weinstein, Milton C.; Goldman, Lee // JAMA: Journal of the American Medical Association;12/6/2000, Vol. 284 Issue 21, p2748 

    Reports on a study of the potential health and economic impact of increased use of beta-blockers in patients who have had myocardial infarction. Design; Setting; Main outcome measures; Results; Conclusion that increased use of beta-blockers after myocardial infarction could lead to gains in...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics